Updated:
re.Mind Capital
re.Mind Capital operates from Sliema, Malta, as an early-stage investment firm focused strictly on companies advancing mental and brain health.
re.Mind Capital
re.Mind Capital operates from Sliema, Malta, as an early-stage investment firm focused strictly on companies advancing mental and brain health. Strategy details are limited in public disclosures, but the firm's narrow mandate targets pre-IPO and early-stage ventures that address mental health and human flourishing. The firm's own materials frame this as a dedicated sector bet, though specific portfolio companies, deal-stage check sizes, and co-investor relationships remain undisclosed in available sources. Scale, team composition, and adjacent vehicles are not publicly documented. The firm has not disclosed its total deployment, professional headcount, or additional office locations beyond Malta. No recent operational events — fund closes, key hires, or portfolio exits — were verifiable in the current source set. The structural differentiator lies in the mandate itself: an entire private equity platform organized around a single, historically undercapitalized vertical. Whether the firm uses direct investments, SPVs, or fund commitments is not publicly known, leaving the operating model opaque but the thematic focus unusually concentrated.
General information
Firm type
Private Equity
Year founded
2020
AUM
Undisclosed
Location
Region
Europe
Country
Malta
City
Sliema
Corporate office
Sliema, Malta
Sector focus
Frequently asked questions
What is re.Mind Capital's sole investment focus?
The firm invests exclusively in early-stage companies centered on mental health, brain health, and human flourishing. This singular focus is the defining feature of its public identity, though the specific technologies, therapeutic areas, or business models it favors are not detailed in public materials.
Does re.Mind Capital invest in digital therapeutics, biotech, or services?
Available source material does not specify. The firm's thematic framing — mental and brain health — spans digital health apps, biopharma, neurotech, and care delivery models, but no public portfolio or investment criteria clarify which sub-segments re.Mind Capital targets or avoids.
Who founded or leads re.Mind Capital?
No named principals have been identified in the sources consulted. The firm's website does not list a founder, managing partner, or investment committee, and no LinkedIn page or third-party profiling captured leadership details.
How much capital has re.Mind Capital deployed?
Neither assets under management nor total deployment has been publicly disclosed. The firm does not publish fund sizes, portfolio valuations, or capital raised, leaving its scale unknown to external allocators and peers.
What is re.Mind Capital's geographic investment footprint?
The firm is headquartered in Malta, but it has not published whether its investments concentrate in Europe, North America, or globally. Without a disclosed portfolio, geographic preferences remain unspecified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: